Search Results for "PSID"
- QUMI Update: Datajack Signs Distribution Agreement Possibly Worth Over $25 Million in Revenue This Year
Penny Stock Quamtel, Inc. (OTCBB: QUMI.OB) subsidiary, DataJack, Inc., and Prouty Company LLC announced today a long-term, comprehensive distribution agreement that will deliver nationwide Mobile Broadband services powered by DataJack through ProutyCo’s extensive network of over 100,000 carri...
- Cannabis Science Presents Visuals Of Cancer Tumors Dying
Cannabis Science, Inc. (OTCBB: CBIS.OB), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, shared new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant...
- Ecoland International’s D&R Technology Inc. is Venturing Into a New Market Segment
D & R Technology Inc., a wholly owned subsidiary of Ecoland International, Inc. (OTCBB: ECIT.OB), announced today the successful completion and receipt of various orders from Faurecia S.A (EO.PA), and Johnson Controls (NYSE:JCI) . The new contracts are result of D&R’s research and de...
- North Springs Resources, NSRS, Launches New Website
North Springs Resources Corp. (OTCBB: NSRS.OB) announced the launch of its newly redesigned website at www.northspringsresources.com. The enhanced site contains new and never before seen photos and maps highlighting each of the Company’s five mineral exploration and development projects. ...
- Intellipharmaceutics Appoints Vice President Business Development
Intellipharmaceutics International Inc. (NASDAQ: IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States subsidiary,Intellipharmaceutics Lt...
- Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2011 after market close on Tuesday February 7, 2012. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day. Conferen...
- FrogAds.com Announces Further Expansion Within the U.S.
FrogAds, Inc. (OTCBB: FROG) announced today that it has rapidly advanced upon its U.S. expansion plans with the opening of its second office on the West Coast. The new office, located in Woodland Hills, California, will serve as the central programming hub of the company and immediately follows the...
- Plandai Biotechnology, Inc., (OTCBB:PLPL), Announces Appointment of World-Renowned Physicist
Plandaí Biotechnology, Inc. (OTCBB: PLPL) Chief Executive Officer, Roger Duffield, today announced that Dr. Tom Matula has accepted the position of Chairman of the Scientific Board for Plandaí Biotechnology, Inc., effective immediately. Dr. Matula is a world-renowned scientist and entrepreneur w...
- GTAT, GT Advanced Technologies Announces Innovative Casting Technology
GT Advanced Technologies Inc., (NASDAQ: GTAT), today announced the commercial availability of its DSS™450 MonoCast™ crystal growth system. Modules produced from material grown in GT’s DSS™450 MonoCast™ furnace rival modules that incorporate traditional boron-doped batch CZ monocrystalline...
- ACTC Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial
Advanced Cell Technology, Inc. (OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Aberdeen Royal Infirmary, the largest of the Grampian University Hospitals in Scotland, has been confirmed as a site for its Phase 1/2 human clinical trial for Stargardt’s Macula...
